Literature DB >> 312471

Humoral immunity before and after thymectomy in myasthenia gravis.

G K Scadding, A D Webster, M Ross, H C Thomas, C W Havard.   

Abstract

Humoral immunity was studied in 10 patients with myasthenia gravis before thymectomy, in 15 different patients over 10 years after thymectomy, and in normal controls. Antibody titers to acetylcholine receptor were significantly (p less than 0.01) lower in the post-thymectomy group. However, other antibody titers to common viruses, and to Escherichia coli, and isohemagglutinins showed no significant change. Levels of IgM and IgE (with atopic subjects excluded) decreased following thymectomy (p less than 0.05). Autoantibodies persisted, apart from those directed against the acetylcholine receptor. The absence of any significant changes in humoral immunity after thymectomy for myasthenia gravis suggests that there is no generalized loss of helper T-cell function.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312471     DOI: 10.1212/wnl.29.4.502

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

Review 3.  The role of surgery of the thymus for myasthenia gravis.

Authors:  C L Robinson
Journal:  Ann R Coll Surg Engl       Date:  1983-05       Impact factor: 1.891

Review 4.  Pathogenesis and treatment of myasthenia gravis.

Authors:  G K Scadding; C W Havard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-17

Review 5.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.

Authors:  A Rødgaard; F C Nielsen; R Djurup; F Somnier; S Gammeltoft
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

Authors:  E Bartoccioni; F Scuderi; C Scoppetta; A Evoli; P Tonali; L Guidi; C Bartoloni; T Terranova
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

8.  When is there a full recovery for a myasthenia gravis patient?

Authors:  C Scoppetta; E Bartoccioni; P David; G Flamini; M Lo Monaco; F Scuderi; P Tonali
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

9.  Levels of Tc17 cells in thymic epithelial cell tumors associated with autoimmune diseases.

Authors:  Jian Li; Yuan Chen; Yuanguo Wang; Yimei Liu; Peng Zhang
Journal:  Mediastinum       Date:  2019-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.